Search

everythinglearnresearchcommunity

for

Search:↓

A reliable severity score for female pattern hair loss was developed and validated.

Certain hair and scalp features indicate a worse outcome in alopecia areata.

Certain hair and scalp features can predict the severity of alopecia areata.

Intradermal PRP significantly improved melasma in dark skin, with lasting results and no relapse after 3 months.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

The treatment with Bakuchiol and Neem oil significantly improved hair growth and was well-received by most participants.

Targeting IL-15 may help treat Alopecia Areata.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Higher IL-21 levels may help predict alopecia areata activity.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Oral minoxidil improved hair loss more than oral dutasteride.

Combining calcipotriol and PRP is most effective for treating Alopecia Areata.

Intralesional pentoxifylline effectively and safely treats alopecia areata, improving hair regrowth.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

The combination of laser and topical steroids is more effective for treating alopecia areata than topical steroids alone.

Baricitinib is more effective than methotrexate for severe alopecia areata.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Upadacitinib improved multiple immune-related conditions in one patient.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Nail changes are common in alopecia areata and can indicate its severity.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.